If someone told you the most effective non-surgical ED treatment involved injecting medication directly into your penis, your first reaction would probably be "absolutely not." That reaction is universal. And yet, men who actually start intracavernosal injection therapy overwhelmingly continue with it — because it works when nothing else does.
What Trimix Is
Trimix is a compounded medication containing three vasoactive agents, each working through a different mechanism:
- Alprostadil (prostaglandin E1): Directly relaxes smooth muscle in the corpus cavernosum, promoting blood flow. This is the same active ingredient in the FDA-approved injection Caverject, but at lower doses in the combination.
- Phentolamine: An alpha-adrenergic blocker that prevents the smooth muscle contraction that counteracts erections. It works synergistically with alprostadil.
- Papaverine: A non-specific smooth muscle relaxant that inhibits phosphodiesterase (similar to oral PDE5 inhibitors, but delivered directly to the target tissue at much higher effective concentrations).
The three-agent combination provides redundancy — even if one pathway is impaired (as in diabetic neuropathy or severe vascular disease), the others compensate. This is why Trimix success rates exceed 85% even in populations where PDE5 inhibitors fail.
The Injection Process
The thought of the injection is worse than the reality. Here's what it actually involves:
The needle: 28 or 30-gauge, half-inch. For reference, this is thinner than most insulin needles. The injection goes into the lateral corpus cavernosum — the side of the penis shaft, avoiding the dorsal neurovascular bundle on top and the urethra on the bottom.
The timing: 5–20 minutes before sexual activity. Onset is faster than any oral medication.
The technique: After proper training from a urologist (typically an in-office session), most men can self-inject in under 30 seconds. The learning curve is 2–3 sessions.
The sensation: Most men describe a brief sting, comparable to a mosquito bite. Once past the initial psychological barrier, the injection itself is rarely cited as the reason men discontinue therapy.
Success Rates and Who Benefits
Trimix is particularly effective for men who fail oral medications due to severe vascular disease (diabetes, post-prostatectomy nerve damage, advanced atherosclerosis). It bypasses the oral-absorption and systemic-circulation limitations of PDE5 inhibitors by delivering vasoactive agents directly to the target tissue.
Risks and Side Effects
Priapism: The most feared complication — an erection lasting more than 4 hours. With proper dose titration (always done in a urologist's office first), this is uncommon (<3% of injections). If it occurs, an antidote injection (phenylephrine) at the ER resolves it. The 4-hour rule is absolute — seek emergency treatment, because prolonged priapism causes irreversible corporal damage.
Penile fibrosis: Repeated injections can cause scar tissue formation at injection sites over time. Rotating injection sites and limiting frequency (generally no more than 3 times per week) minimizes this risk.
Pain: Alprostadil can cause a burning or aching sensation. The Trimix formulation reduces this compared to alprostadil alone because the dose of each component is lower.
Bruising: Minor bruising at the injection site is common and resolves within days.
Practical Considerations
Storage: Trimix must be refrigerated and has a limited shelf life (typically 30–90 days depending on formulation). Heat degrades the medication.
Cost: Compounded Trimix typically costs $50–150 per vial (containing 5–20 doses depending on your titrated amount). It requires a prescription and is obtained from compounding pharmacies.
Titration: The first dose is always administered in a urologist's office to establish the correct amount. Starting doses are very low and increased gradually. Never adjust your dose without medical guidance — the margin between effective dose and priapism-risk dose varies by individual.